Filter
781
Filtered Results: 781
Text search:
WHO
Regional
Office
for
the
Eastern
Mediterranean
Featured
Recommendations
114
New Publications
153
Language
Document type
No document type
265
Studies & Reports
205
Guidelines
141
Manuals
64
Strategic & Response Plan
44
Training Material
17
Fact sheets
15
Situation Updates
13
Infographics
7
Resource Platforms
6
Brochures
1
App
1
Online Courses
1
Videos
1
Countries / Regions
Global
72
Syria
25
Africa
20
Middle East and North Africa
19
Western and Central Europe
16
Somalia
10
Yemen
10
South–East Asia Region
9
Ethiopia
7
Sudan
7
West and Central Africa
7
Latin America and the Carribbean
7
Pakistan
6
East and Southern Africa
6
Eastern Europe
6
Liberia
5
Nigeria
5
Myanmar / Burma
5
Sierra Leone
4
Iraq
4
Jordan
4
Afghanistan
4
Lebanon
4
Eastern Europe and Central Asia
4
Iran
4
Saudi Arabia
3
Ghana
3
Uganda
3
India
3
Turkey
3
Kenya
3
Rwanda
3
Asia
3
Venezuela
3
Senegal
2
Congo, Democratic Republic of
2
Philippines
2
Nepal
2
Thailand
2
China
2
South Africa
2
Bangladesh
2
North Macedonia
2
Ukraine
2
Libya
2
Western Pacific Region
2
Morocco
1
USA
1
Cameroon
1
Egypt
1
Tanzania
1
Cambodia
1
Benin
1
Central African Republic
1
Croatia
1
Ecuador
1
Greece
1
Mexico
1
Chile
1
Paraguay
1
Palestine
1
Albania
1
Djibouti
1
Russia
1
Qatar
1
Georgia
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
113
Countries
99
Public Health
86
Women & Child Health
69
Key Resources
41
Capacity Building
25
Pharmacy & Technologies
17
Toolboxes
Mental Health
91
COVID-19
90
Rapid Response
51
Planetary Health
46
TB
41
HIV
40
Caregiver
34
NTDs
34
Refugee
33
Conflict
32
Global Health Education
29
AMR
29
Disability
24
NCDs
24
Pharmacy
20
Polio
12
Ebola
11
Cholera
7
Natural Hazards
7
Zika
7
Specific Hazards
4
Health Financing Toolbox
4
Typhoon
1
Social Ethics
1
According to the Report, cascading and interlinked crises are putting the 2030 Agenda for Sustainable Development in grave danger, along with human...
World Psychiatry. 2010 Jun;9(2):67-77.
The main recommendations are presented in relation to: the need for coordinated policies, plans and program...
A comprehensive compilation is provided of the medicinal plants of the Southeast Asian country of Myanmar (formerly Burma). This contribution, containing 123 families, 367 genera, and 472 species, w...
The report offers 20 top recommendations for getting ahead of future outbreaks in Yemen and similarly complex humanitarian settings.
In 2015, Yemen was declared a Level 3 emergency by ... UN, kicking into gear the highest level of humanitarian support. A massive cholera outbreak followed, leading to 1 million suspected cases in 2 waves from September 2016-July 2018.
“We largely know ‘what to do’ to control cholera, but context-specific practices on ‘how to do it’ in order to surmount challenges to coordination, logistics, insecurity, access and politics remain needed,” the report states.
While the response improved between the 2 waves, there were gaps. For one, Yemen’s history of cholera should have triggered a heavy focus on pre-planning for an epidemic, such as stockpiling supplies and doubling down on community-based surveillance, the report fou
Reduce Risk, Protect Health Facilities, Save Lives
The GHS Index is intended to be a key resource in the face of increasing risks of high-consequence and globally catastrophic biological events and in light of major gaps in international financing <... preparedness. These risks are magnified by a rapidly changing and interconnected world; increasing political instability; urbanization; climate change; and rapid technology advances that make it easier, cheaper, and faster to create and engineer pathogens.
Key findings from the study of 195 countries:
• Out of a possible 100 points, the average GHS Index score across 195 countries was 40.2.
• The majority of high- and middle-income countries do not score above 50.
• Action is urgently needed to improve countries’ readiness for high-consequence infectious disease outbreaks.
National action plans on antimicrobial resistance (AMR) often overlook the critical intersection of gender, despite evidence that exposure and susceptibility to infection, health-seeking behaviours, as well as antimicrobial prescribing and use patte...
Only 8,730 asylum applications were registered in the EU+ in April, the lowest since at least 2008, and a massive 87% decrease from pre-COVID-19 levels in January and February.
... European Asylum Support Office (EASO) has released a special report which shows that the COVID-19 related travel restrictions and national health measures which were imposed during the past few months led to a dramatic cut in asylum applications in Europe.
Guide for tutors
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection...
The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalised anxiety and sleep disorders; obsessive-compulsive disorders and panic attacks; an...
Manual for Early Implementation
Out of the shadows
Global concerns: Implications for the future
Child Mental Health Atlas
The global emergence of antimicrobial resistance (AMR) is posing a threat to human health. Putting resources into the containment of AMR – including surveillance – is one of ... highest-yield investments a country can make to mitigate its impact. In 2015, WHO launched the Global Antimicrobial Resistance Surveillance System (GLASS), the first global collaborative effort to foster AMR surveillance in bacteria causing acute infections. As of December 2018, 71 countries are enrolled in GLASS. The aim of this report is to document participation efforts and outcomes across these countries, and highlight differences and constraints identified to date. This report follows on from the first GLASS Report – Early implementation 2016-17, published in January 2018, and drawing on data from GLASS first data call in 2017.
The report reveals that good IPC programmes can reduce health care infections by 70 %. oday, out of every 100 patients in acute-care hospitals, seven patients in high-income countries and 15 patients in low- and middle-income countries will acquire ...
This document provides guidance on how to implement contact screening and chemoprophylaxis with single-dose rifampicin. The contents are logically ordered: counselling and obtaining consent, identification and listing of index case, listing of conta...
In 2013 the World Health Organization (WHO) published the report Protecting health from climate change:vulnerability and adaptation assessment. ... aim was to provide basic and flexible guidance on conducting national or subnational assessments of current and future vulnerability (the susceptibility of a population or region to harm) to the health risks of climate change, and of policies and programmes that could increase resilience, taking into account the multiple determinants of climate-sensitive health outcomes.
That guidance has been a very useful tool, applied to more than 50 countries and settings, and has helped countries to prepare their health contributions to United Nations Framework Convention on Climate Change national adaptation plans.
Since the launch of the guidance, WHO, technical partners such as Health Canada, and countries have learned much in terms of its applicability in different countries, at national and local levels.
At the same time, knowledge on climate change and health has increased.
WHO, the Pan American Health Organization and Health Canada have produced this updated version, which aims to better support countries in their assessments by proposing a simpler tool that incorporates
all lessons learned.
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, ... has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and performance of key national pharmaceutical structures and processes. Level II indicators measure key outcomes of these structures and processes in the areas of access, product quality and rational use. These indicators can be used to assess progress over time; to compare situations between countries; and to reassess and prioritize efforts based on the results.
This Fact Book gives the results of the assessment of Level I indicators conducted in 2003 and of Level II indicator surveys conducted between 2002 and 2004
